January 26, 2012
Drug Company Executives Are Expanding Their Use of Strategic Partnerships
Jan. 17, 2012
Tufts Center for the Study of Drug Development Establishes Workload and Utilization Benchmarks for Global Clinical Research Asso
Nov. 17, 2011
Tufts CSDD presents a Forum on the Impact of CER on Biopharmaceutical Innovation and Patient Access
Nov. 8, 2011
Number of Monoclonal Antibody Products in Development Continues to Increase
Sept. 13, 2011
Majority of Clinical Trial Protocols Are Amended, But One-Third of Those Changes Are Avoidable
July 19, 2011
Lack of Clinically Useful Diagnostics Hinder Growth in Personalized Medicines
March 8, 2011
U.S. Approvals of Supplemental Drug Indications Have Been Rising Steadily
January 27, 2011
Translational Science Expected to Play a Growing Role in Creating New Drugs
January 12, 2011
U.S. Healthcare Stakeholders Uncertain about Benefits of Risk Evaluation Program
February 6-10, 2012
Tufts CSDD Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation
February 23, 2012
Managing the Transition from Nonclinical to Early Clinical Development
Tufts Center for the
Study of Drug Development
Tufts University
75 Kneeland Street
Suite 1100
Boston, MA 02111
USA
Phone: 617-636-2170
Fax: 617-636-2425
E-mail: csdd@tufts.edu
Copyright © 2012
Tufts Center for the
Study of Drug Development
All Rights Reserved